See every side of every news story

Published 7 hours ago • loading... • Updated 6 hours ago

How Cost and Perception Could Reshape the GLP-1 Market

Summary by PharmaVOICE

As Eli Lilly and Novo Nordisk race for share, surveys show affordability and prescribing preferences may help decide the winners.

3 Articles

3 Articles

Dispute Between Eli Lilly and Novo Nordisk Boosts Market for Weight Loss Pills

A new battle is taking place between Eli Lilly and Novo Nordisk — and it can boost the market for weight loss medicines, designed to reach $200 billion. Exclusive material for subscribers. To have full access, access the link of the material and register.

6 hours ago·Rio de Janeiro, Brazil

Read Full Article

Investor's Business Daily

Lilly Is Trailing In Obesity Pills; How Long Will That Last?

The weight-loss pills battle between Eli Lilly and Novo Nordisk could add to the projected $200 billion market for obesity drugs.

7 hours ago·Los Angeles, United States

Read Full Article

How cost and perception could reshape the GLP-1 market

As Eli Lilly and Novo Nordisk race for share, surveys show affordability and prescribing preferences may help decide the winners.

12 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources3

Leaning Left0Leaning Right2Center1Last Updated2 hours agoBias Distribution

67% Right

Bias Distribution

67% of the sources lean Right

67% Right

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PharmaVOICE broke the news 12 hours ago on Wednesday, August 19, 2026.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics